
Reducing the Usage of Oral Corticosteroids in the Management of Asthma
These podcasts are designed to assist members of the multidisciplinary respiratory care team in identifying approaches to improve patient care for those with moderate-to-severe asthma. Reducing the reliance on oral corticosteroids through the use of targeted biologic agents will be discussed. Additionally, the risks associated with even short courses of low-dose prednisone will be reviewed. This program features expert analysis of the latest clinical trial outcomes of biologic therapies, as well as guidance on when referral to a specialist is appropriate.
RELEASED DATE: March 28, 2024
EXPIRATION DATE: March 28, 2025